PSP Research »

Immunome shares owned by PSP Research

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $437k 20k 21.87
2025-12-31 $542k 25k 21.48

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Point72 Asset Management
Vanguard Group
Redmile Group
Enavate Sciences GP
PRIMECAP Management Company
Leucadia National Corporation
State Street Corporation
Driehaus Capital Management
EcoR1 Capital
Geode Capital Management
Citadel Advisors
Readystate Asset Management

View all funds holding Immunome